BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 33340121)

  • 1. Simultaneous detection of fetal aneuploidy, de novo FGFR3 mutations and paternally derived β-thalassemia by a novel method of noninvasive prenatal testing.
    Yang L; Wu Y; Hu Z; Zhang H; Pu D; Yan H; Zhang S; Jiang H; Liu Q; Yuan Y; Zhang Y; Chen F; Lu Y; Pan S; Lin L; Gao Y
    Prenat Diagn; 2021 Mar; 41(4):440-448. PubMed ID: 33340121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noninvasive prenatal testing of beta-thalassemia for common Pakistani mutations: a comparative study using cell-free fetal DNA from maternal plasma and chorionic villus sampling.
    Afzal M; Naeem MA; Ahmed S; Amin N; Rahim A; Munawar M; Ishaq M; Rathore A; Maria K
    Hematology; 2022 Dec; 27(1):353-359. PubMed ID: 35287566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of paternally inherited fetal point mutations for β-thalassemia in maternal plasma using simple fetal DNA enrichment protocol with or without whole genome amplification: an accuracy assessment.
    Ramezanzadeh M; Salehi M; Farajzadegan Z; Kamali S; Salehi R
    J Matern Fetal Neonatal Med; 2016; 29(16):2645-9. PubMed ID: 26553322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiplex PCR in noninvasive prenatal diagnosis for FGFR3-related disorders.
    Terasawa S; Kato A; Nishizawa H; Kato T; Yoshizawa H; Noda Y; Miyazaki J; Ito M; Sekiya T; Fujii T; Kurahashi H
    Congenit Anom (Kyoto); 2019 Jan; 59(1):4-10. PubMed ID: 29542187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noninvasive Prenatal Diagnosis of Beta-Thalassemia Disease by Using Digital PCR Analysis of Cell-Free Fetal DNA in Maternal Plasma.
    Charoenkwan P; Traisrisilp K; Sirichotiyakul S; Phusua A; Sanguansermsri T; Tongsong T
    Fetal Diagn Ther; 2022; 49(11-12):468-478. PubMed ID: 36574763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noninvasive prenatal test for FGFR3-related skeletal dysplasia based on next-generation sequencing and plasma cell-free DNA: Test performance analysis and feasibility exploration.
    Ren Y; Zhao J; Li R; Xie Y; Jiang S; Zhou H; Liu H; You Y; Chen F; Wang W; Gao Y; Meng Y; Lu Y
    Prenat Diagn; 2018 Oct; 38(11):821-828. PubMed ID: 30048571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome-Wide Noninvasive Prenatal Diagnosis of De Novo Mutations.
    Peretz-Machluf R; Rabinowitz T; Shomron N
    Methods Mol Biol; 2021; 2243():249-269. PubMed ID: 33606261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-invasive cell-free fetal DNA testing for aneuploidy: multicenter study of 31 515 singleton pregnancies in southeastern China.
    Xu L; Huang H; Lin N; Wang Y; He D; Zhang M; Chen M; Chen L; Lin Y
    Ultrasound Obstet Gynecol; 2020 Feb; 55(2):242-247. PubMed ID: 31364782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noninvasive prenatal testing for fetal subchromosomal copy number variations and chromosomal aneuploidy by low-pass whole-genome sequencing.
    Yu D; Zhang K; Han M; Pan W; Chen Y; Wang Y; Jiao H; Duan L; Zhu Q; Song X; Hong Y; Chen C; Wang J; Hui F; Huang L; Chen C; Du Y
    Mol Genet Genomic Med; 2019 Jun; 7(6):e674. PubMed ID: 31004415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequencing shorter cfDNA fragments improves the fetal DNA fraction in noninvasive prenatal testing.
    Qiao L; Yu B; Liang Y; Zhang C; Wu X; Xue Y; Shen C; He Q; Lu J; Xiang J; Li H; Zheng Q; Wang T
    Am J Obstet Gynecol; 2019 Oct; 221(4):345.e1-345.e11. PubMed ID: 31125545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic evaluation of NIPT aneuploidy detection software tools with clinically validated NIPT samples.
    Paluoja P; Teder H; Ardeshirdavani A; Bayindir B; Vermeesch J; Salumets A; Krjutškov K; Palta P
    PLoS Comput Biol; 2021 Dec; 17(12):e1009684. PubMed ID: 34928946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A retrospective analysis the clinic data and follow-up of non-invasive prenatal test in detection of fetal chromosomal aneuploidy in more than 40,000 cases in a single prenatal diagnosis center.
    Luo Y; Hu H; Jiang L; Ma Y; Zhang R; Xu J; Pan Y; Long Y; Yao H; Liang Z
    Eur J Med Genet; 2020 Sep; 63(9):104001. PubMed ID: 32622960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noninvasive prenatal diagnosis of β-thalassemia by relative haplotype dosage without analyzing proband.
    Li H; Du B; Jiang F; Guo Y; Wang Y; Zhang C; Zeng X; Xie Y; Ouyang S; Xian Y; Chen M; Liu W; Sun X
    Mol Genet Genomic Med; 2019 Nov; 7(11):e963. PubMed ID: 31566929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noninvasive prenatal diagnosis experience in the Çukurova Region of Southern Turkey: detecting paternal mutations of sickle cell anemia and β-thalassemia in cell-free fetal DNA using high-resolution melting analysis.
    Yenilmez ED; Tuli A; Evrüke IC
    Prenat Diagn; 2013 Nov; 33(11):1054-62. PubMed ID: 23836351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Causes of aberrant non-invasive prenatal testing for aneuploidy: A systematic review.
    Samura O; Okamoto A
    Taiwan J Obstet Gynecol; 2020 Jan; 59(1):16-20. PubMed ID: 32039788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-invasive prenatal testing of beta-hemoglobinopathies using next generation sequencing, in-silico sequence size selection, and haplotyping.
    Erlich HA; Ko L; Lee J; Eaton K; Calloway CD; Lal A; Das R; Jamwal M; Lopez-Pena C; Mack SJ
    Croat Med J; 2024 Jun; 65(3):180-188. PubMed ID: 38868964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noninvasive prenatal screening in twin pregnancies with cell-free DNA using the IONA test: a prospective multicenter study.
    Khalil A; Archer R; Hutchinson V; Mousa HA; Johnstone ED; Cameron MJ; Cohen KE; Ioannou C; Kelly B; Reed K; Hulme R; Papageorghiou AT
    Am J Obstet Gynecol; 2021 Jul; 225(1):79.e1-79.e13. PubMed ID: 33460583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noninvasive prenatal testing for chromosome aneuploidies and subchromosomal microdeletions/microduplications in a cohort of 42,910 single pregnancies with different clinical features.
    Chen Y; Yu Q; Mao X; Lei W; He M; Lu W
    Hum Genomics; 2019 Nov; 13(1):60. PubMed ID: 31783780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noninvasive Prenatal Testing for Trisomies 21, 18, and 13, Sex Chromosome Aneuploidies, and Microdeletions in Average-Risk Pregnancies: A Cost-Effectiveness Analysis.
    Xie X; Wang M; Goh ES; Ungar WJ; Little J; Carroll JC; Okun N; Huang T; Rousseau F; Dougan SD; Tu HA; Higgins C; Holubowich C; Sikich N; Dhalla IA; Ng V
    J Obstet Gynaecol Can; 2020 Jun; 42(6):740-749.e12. PubMed ID: 32008974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility of noninvasive prenatal testing for common fetal aneuploidies in an early gestational window.
    Shi X; Zhang Z; Cram DS; Liu C
    Clin Chim Acta; 2015 Jan; 439():24-8. PubMed ID: 25286007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.